Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Jan Biotech, Inc. in August, 2020 for $291,256.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI155075-01 | Phase II | 291,256 | August 7, 2020 | |||||||
A SBIR Phase I contract was awarded to Jan Biotech, Inc. in September, 2022 for $275,766.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43GH002389-01A1 | Phase I | 275,766 | September 30, 2022 | |||||||
A STTR Phase I contract was awarded to Jan Biotech, Inc. in December, 2018 for $149,999.0 USD from the U.S. Department of Defense and United States Army. | STTR | W911NF-19-P-0014 | Phase I | 149,999 | December 13, 2018 | |||||||
A STTR Phase II contract was awarded to Jan Biotech, Inc. in November, 2019 for $1,000,000.0 USD from the U.S. Department of Defense and United States Army. | STTR | W911NF-20-C-0014 | Phase II | 1,000,000 | November 21, 2019 | |||||||
A SBIR Phase I contract was awarded to Jan Biotech, Inc. in August, 2015 for $213,238.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DE025437-01 | Phase I | 213,238 | August 15, 2015 | |||||||
A STTR Phase I contract was awarded to Jan Biotech, Inc. in March, 2015 for $356,556.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI116358-01A1 | Phase I | 356,556 | March 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Jan Biotech, Inc. in June, 2016 for $288,893.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124956-01 | Phase I | 288,893 | June 15, 2016 | |||||||
A SBIR Phase II contract was awarded to Jan Biotech, Inc. in August, 2017 for $2,997,824.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI116358-02A1 | Phase II | 2,997,824 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Jan Biotech, Inc. in September, 2023 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI179304-01 | Phase I | 300,000 | September 1, 2023 |